[
    {
      "id": "PR-101",
      "content": "Experimental cancer therapy ‘NeoCure’ in Phase II trials. Targeting advanced breast carcinoma.",
      "metadata": "Trial code: NC-P2, sponsor: Sunrise Pharma, results expected Q4 2025"
    },
    {
      "id": "PR-102",
      "content": "Antiviral drug ‘Viraxin-B’ for respiratory viruses in Phase I. Animal studies showed reduced lung inflammation.",
      "metadata": "Lab reference: Lab-X, next milestone: 2025-06, candidate for fast-track"
    },
    {
      "id": "PR-103",
      "content": "Pain management patch ‘Analge-Patch’ reformulated to minimize skin irritation. Preclinical data promising.",
      "metadata": "Formulation code: AP-NEW, tested for 12-hour release, next step: IND filing"
    },
    {
      "id": "PR-104",
      "content": "Diabetes injection device integrated with real-time glucose monitor. Collaboration with MedTech Solutions.",
      "metadata": "Pilot code: DIA-Sync, user trials: Q3 2025"
    },
    {
      "id": "PR-105",
      "content": "Generic antibiotic ‘Ampiclox-XYZ’ improved shelf life. Stability studies ongoing with updated excipients.",
      "metadata": "Shelf life target: 3 years, scale-up batch planned 2025-07"
    }
  ]
  